Overall Survival among subjects who receive at least one dose of blinded study therapy Approximately 41 months after the 1st subject is randomized [clinicaltrials_resource:4830e97f9c44e3b68722f7dae59172ec]
Ipilimumab: IV solution, Intravenous (IV), 10 mg/kg, Once every 3 weeks for 4 doses, then every 12 weeks, Until progression of disease or unacceptable toxicity, or until the maximum treatment period of 3 years is reached
Etoposide: IV solution, IV, 100 mg/m2, Days 1-3 every 3 weeks, 4 cycles
Cisplatin: IV solution, IV, 75 mg/m2, Once every 3 weeks, 4 doses
Carboplatin: IV Solution, IV, Area Under the Curve (AUC) 5, Once every 3 weeks, 4 doses
clinicaltrials_vocabulary:secondary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:secondary-outcome]
Overall Survival among subjects who receive at least one dose of blinded study therapy Approximately 41 months after the 1st subject is randomized [clinicaltrials_resource:4830e97f9c44e3b68722f7dae59172ec]
Ipilimumab: IV solution, Intravenous (IV), 10 mg/kg, Once every 3 weeks for 4 doses, then every 12 weeks, Until progression of disease or unacceptable toxicity, or until the maximum treatment period of 3 years is reached
Etoposide: IV solution, IV, 100 mg/m2, Days 1-3 every 3 weeks, 4 cycles
Cisplatin: IV solution, IV, 75 mg/m2, Once every 3 weeks, 4 doses
Carboplatin: IV Solution, IV, Area Under the Curve (AUC) 5, Once every 3 weeks, 4 doses
Bio2RDF identifier
4830e97f9c44e3b68722f7dae59172ec
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:4830e97f9c44e3b68722f7dae59172ec
measure [clinicaltrials_vocabulary:measure]
Overall Survival among subjects who receive at least one dose of blinded study therapy
time frame [clinicaltrials_vocabulary:time-frame]
Approximately 41 months after the 1st subject is randomized
description
Ipilimumab: IV solution, Intra ...... 5, Once every 3 weeks, 4 doses
identifier
clinicaltrials_resource:4830e97f9c44e3b68722f7dae59172ec
title
Overall Survival among subject ...... the 1st subject is randomized
@en
type
label
Overall Survival among subject ...... 0e97f9c44e3b68722f7dae59172ec]
@en